- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Dr. Lal PathLabs' Board approved financial results for the quarter and half-year. They declared a ₹7 interim dividend and a 1:1 bonus share issue, utilizing ₹83.77 Cr from securities premium. Authorized capital also increased from ₹107.96 Cr to ₹200 Cr.